NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

Filter By:
Letter to HHS Secretary on Medication Access
10/05/2022
Letter to HHS Secretary Becerra, regarding implementation of the Inflation Reduction Act with a focus on the prescription drug provisions.
Letter to Congressional Committee Leadership on Mental Health Funding
10/05/2022
Letter to Senate Finance & House Ways & means leadership, expressing support for modified Legacy IRA Act provision in both the House passed Securing a Strong Retirement Act and the Senate Finance Committee passed Enhancing American Retirement Now (EARN) Act.
Regulatory Comment to HHS Secretary on Health Equity
10/03/2022
Regulatory comments to HHS Secretary Becerra, on the Section 1557 Nondiscrimination in Health Programs and Activities proposed rule.
Letter to Congressional Committee Leadership on Health Coverage, Medicaid & Medicare
09/20/2022
Letter to House Ways and Means Committee leadership, expressing support for scheduling a markup on key pieces of legislation that will make it easier for people to access critical mental health and substance use disorder services.
Letter to Congressional Leadership on Mental Health Workforce
09/08/2022
Letter to Congressional leadership, expressing support for H.R. 8151 and S. 3479, the Building a Sustainable Workforce for Healthy Communities Act, which strengthens federal support for community health workers in medically underserved communities.
Letter to HHS Secretary on COVID-19
08/25/2022
Letter to HHS Secretary Becerra, requesting that the Department of Health and Human Services takes proactive steps to integrate mental health and substance use throughout the operations of the newly-formed the Administration for Strategic Preparedness and Response.
Letter to Congressional Leadership on Medicare and Medication Access
08/04/2022
Letter to Senate leadership, submitting feedback on select provisions related to Medicare Part D contained in The Inflation Reduction Act of 2022.
Letter to Congressional Committee Leadership on Research and Innovation and Mental Health Funding
07/27/2022
Letter to Senate HELP committee leadership, expressing support for including funding to enhance the evidence-based Collaborative Care Model (CoCM) within H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022.
Letter to Congressional Bill Sponsors on Medicare & Medicaid
07/11/2022
Letter to Senators Brown and Portman, in support of the "All-Inclusive Medicare-Medicaid (AIM) Program for Full-Benefit Dual Eligible Individuals Act," which would create of a new permanent option for states to integrate program financing, administration, eligibility processes, and benefits for dual-eligibles.
Letter to Congressional Bill Sponsors on Research and Innovation & Child and Adolescent Mental Healthh
07/11/2022
Letter to Senators Smith and Murkowski, expressing support for the Improving Data Collection for Adverse Childhood Experiences Act, which will build upon previous studies on Adverse Childhood Experiences (ACEs) in innovative and equitable ways.
Displaying results 11-20 (of 202)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >